Professor Dr Mathias Bähr

  • Section Neurosciences
  • Location Göttingen, Germany
  • Election year 2005

Research

Besides his clinical expertise Mathias Bähr is internationally well known for his contributions to basic neuroscience research fields like neuroprotection and neuroregeneration.
In his more than 200 original publications in leading international journals in the field he has described in detail the cellular and molecular basis of neurodegeneration in animal models of stroke, multiple sclerosis and parkinson’s disease and developed new experimental therapeutic approaches, some of which have already entered clinical phase testing.
He is currently one of the speakers of the DFG Research Center ‘Molecular Physiology of the Brain (CMPB)’ and the Excellence Cluster Center for Nanoscale Microscopy and Molecular Physiology of the Brain (CNMPB) at the Göttingen research campus.

  • since 2001 Head of the Department of Neurology, University of Göttingen, Germany
  • 1996-2001 Associate Professor, Schilling-Foundation Professorship, University Hospital Tübingen, Germany
  • 1994-1996 Senior resident, Assistant Professor and Lecturer, Department of Neurology, University of Tübingen, Germany
  • 1993 Habilitation, University Tübingen, Germany
  • 1989-1993 Resident, Department of Neurology, University of Tübingen, Germany
  • 1988-1989 Max Planck Fellowship, Department of Anatomy and Neurobiology Washington University St. Louis, USA
  • 1987-1990 Post-doctoral Fellowship, Max Planck Institute for Developmental Neurobiology, Germany (Prof. F. Bonhoeffer)
  • 1986 Ph.D., Department of Neuropathology, Medical School, University of Tübingen, Germany
  • 1985 M.D., Medical School, University of Tübingen, Germany
  • 1979-1985 Medical student at the University of Tübingen, Germany

  • since 2009 First speaker of the “Center of Molecular Physiology of the Brain – CMPB”
  • since 2008 Member of the Academy of Sciences and Humanities Göttingen, Germany
  • since 2007 Member Board of the German-Israeli-Foundation (GIF)
  • since 2007 Fellow of the Royal Academy of Physicians, London, UK
  • 2007 President of the German Society for Neurosciences
  • since 2006 Board Member of the Gertrud Reemtsma-Foundation
  • since 2005 Elected Member of the German Academy of Sciences Leopoldina
  • since 2002 Member of the National Ethics Committee on Stem Cell Research in Germany
  • since 2001 Member of the Board of Directors, European Neuroscience Institute

  • Coordinator of the division 'Aggregation-Disorders', Excellence Cluster CNMBP
  • since 2008 Coordinator of an EU-Project “Advanced gene therapy tools for treatment of CNS specific disorders” (NEUGENE)

The Leopoldina uses cookies

We use cookies on our website. Some of them are necessary (functional cookies), while others are not necessary but help us to improve our online offering and operate it economically.

You can consent to the use of non-essential cookies by clicking on the "Accept all" button or by clicking on individual settings and agreeing to them by clicking on "Accept selection".

You can access these settings at any time and deselect cookies at a later date.

Functional

These cookies are technically necessary in order to provide the following core functionalities of the website:

  • Display of the website
  • Anonymisation of IP addresses within log files
  • Status cookie consent
Comfort

In addition to necessary cookies, we also use cookies to make your use of the website more pleasant. If you accept these cookies, external media will be loaded without your further consent.

Tracking

With the help of statistics cookies, we can better customise the content and services of our website to your interests and needs. For statistics and analyses, we use the product Matomo for statistics and analyses.

External link warning

Die Nutzung dieses Teildienstes erfordert ihre Einwilligung in die Verarbeitung zusätzlicher personenbezogener Daten durch einen selbständigen Verantwortlichen: Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gelten folgende Datenschutzhinweise: https://matterport.com/de/node/44. Mit der Einwilligung durch Klick auf „Ok“ kann auch eine Übermittlung von personenbezogenen Daten in ein Land außerhalb der Europäischen Union erfolgen. Die Einwilligung ist freiwillig. Eine Ablehnung führt zu keinen Nachteilen. Eine erteilte Einwilligung kann jederzeit mit Wirkung für die Zukunft widerrufen werden.

Ich bin damit einverstanden, dass bei Nutzung dieses Teildienstes zusätzliche personenbezogene Daten verarbeitet werden. Dabei verarbeitete Datenkategorien: technische Verbindungsdaten des Serverzugriffs (IP-Adresse, Datum, Uhrzeit, abgefragte Seite, Browser-Informationen), Daten zur Erstellung von Nutzungsstatistiken und Daten über die Nutzung der Website sowie die Protokollierung von Klicks auf einzelne Elemente. Zweck der Verarbeitung: Auslieferung von Inhalten, die von Dritten bereitgestellt werden. Rechtsgrundlage für die Verarbeitung: Ihre Einwilligung nach Art. 6 (1) a DSGVO, Art. 49 DSGVO. Verantwortlicher für die Datenverarbeitung Matterport Inc., 352 E. Java Drive, Sunnyvale, CA 94089, USA. Es gilt die Datenschutzerklärung von Matterport Inc.: https://matterport.com/de/node/44.

Visit page ▸